Retatrutide is contraindicated in individuals with personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia type 2, pancreatitis history, or uncontrolled cardiovascular disease
It includes L-Carnitine COA review, purity support, identity information, lot number matching, storage and handling notes, and supplier language
doi:10.1017/s0007114516003858 Rezaie P, Bitarafan V, Horowitz M, Feinle-Bisset C
The Pharmaceutical Journal endeavours to cover further developments about this drug class and latest associated studies in our wider content offering
Yes, it is FDA-approved and administered under medical supervision for maximum safety and effectiveness
According to a study of 30 healthy adults, ingesting 0.5 grams of allulose per kilogram of body weight caused gastrointestinal problems in certain people, such as severe diarrhea, nausea, and bloating